Avatar

Prognostic Markers in Follicular Lymphoma, FLIPI Score and Results of PRIMA and FLASH Study

By Carla Casulo
414 views
October 26, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
27:49
MyCancerHaven

Overview of the Diagnosis and Treatment of Follicular Lymphoma

Feat. R. Vij, T. Fehniger
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Lymphoma Bispecific Antibody Therapy and Management of CRS

Feat. D. Land, M. Hughes
12:37
SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Follicular Lymphoma

Feat. G. Salles
15:35
2021 Virtual ESMO Review

ESMO 2021 Highlights on Lymphomas: R/R Marginal Zone Lymphoma, PMLBC…

Feat. J. Vose
19:21
2021 Virtual ESMO Review

ESMO 2021 Hematologic Malignancies Panel Discussion

Feat. J. Vose, H. Erba
21:14
8th Eurasian Hematology Oncology Summit

2021 Treatment Considerations for Follicular Lymphoma: Localized, Ad…

Feat. G. Gaidano
14:50
7th Eurasian Hematology Oncology Summit

How I Treat Follicular Lymphoma in 2020: Rituximab vs. WW Strategy, …

Feat. G. Gaidano
18:02
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Molecular Pathogenesis of FL and Its Relevance to Clinica…

Feat. J. Okosun
10:49
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Follicular Lymphoma - Next Steps: What is the First-Line Standard in…

Feat. R. Marcus
10:59
2018 Pan Pacific Lymphoma Conference

A Brief Introduction to the Evolving Role of Genomics in NHL with Ca…

Feat. A. Zelenetz
17:19
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Follicular Lymphoma - Bendamustine and Rituximab as Preferred Treatm…

Feat. M. Rummel
18:05
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Managing High Risk/Relapsed Follicular Lymphoma

Feat. N. Fowler
15:30

Follicular Lymphoma Prognosis and Recent Changes in Diagnosis

21:17
2018 Pan Pacific Lymphoma Conference

Burkitt Lymphoma- R-Epoch for All?

Feat. M. Roschewski
13:32
2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment: A Rational Therapeutic Target in Indolen…

Feat. J. Gribben
45:59
Bruce Cheson

Intro to Follicular and Other Indolent Lymhomas

14:55
Indy Hematology Review

Intro to Lymphoma: Emerging Therapies

Feat. B. Cheson
27:08
2018 Pan Pacific Lymphoma Conference

Clinical Trials for Patients with Lymphoma: How to Enroll More Patie…

Feat. J. Leonard
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl